UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The global burden of hepatitis E virus genotypes 1 and 2 in 2005

Hepatology (Baltimore, Md.), 2012-04, Vol.55 (4), p.988-997

2012

Volltextzugriff (PDF)

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

Annals of internal medicine, 2012-02, Vol.156 (4), p.263

2012

Volltextzugriff (PDF)

The Economic Burden of Vision Loss and Eye Disorders among the United States Population Younger than 40 Years

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1728-1735

2013

Volltextzugriff (PDF)

Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance

JAMA ophthalmology, 2023-06, Vol.141 (6), p.534

2023

Volltextzugriff (PDF)

The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics

Hepatology (Baltimore, Md.), 2016-04, Vol.63 (4), p.1135-1144

2016

Volltextzugriff (PDF)

A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening

American journal of kidney diseases, 2010-03, Vol.55 (3), p.463-473

2010

Volltextzugriff (PDF)

Cost-Effectiveness of Screening for Microalbuminuria among African Americans

Journal of the American Society of Nephrology, 2012-12, Vol.23 (12), p.2035-2041

2012

Volltextzugriff (PDF)

Prevalence of Age-Related Macular Degeneration in the US in 2019

JAMA ophthalmology, 2022-12, Vol.140 (12), p.1202

2022

Volltextzugriff (PDF)

Bringing Eye Care to the People

JAMA ophthalmology, 2024-10, Vol.142 (10), p.916

2024

Volltextzugriff (PDF)

Prevalence of Diabetic Retinopathy in Health Care Settings-An Early Warning Sign?

JAMA ophthalmology, 2024-07, Vol.142 (7), p.607

2024

Volltextzugriff (PDF)

Public Attitudes About Eye and Vision Health

JAMA ophthalmology, 2016-10, Vol.134 (10), p.1111

2016

Volltextzugriff (PDF)

A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences

American journal of kidney diseases, 2010-03, Vol.55 (3), p.452-462

2010

Volltextzugriff (PDF)

Prevalence of Diabetic Retinopathy in the US in 2021

JAMA ophthalmology, 2023-08, Vol.141 (8), p.747

2023

Volltextzugriff (PDF)

The Economic Burden of Vision Loss and Blindness in the United States

Ophthalmology (Rochester, Minn.), 2022-04, Vol.129 (4), p.369-378

2022

Volltextzugriff (PDF)

Behavioral Risk Factor Surveillance System and American Community Survey Estimates of Vision Difficulty Prevalence

JAMA ophthalmology, 2024-08, Vol.142 (8), p.768

2024

Volltextzugriff (PDF)

The Cost-effectiveness of Routine Office-based Identification and Subsequent Medical Treatment of Primary Open-Angle Glaucoma in the United States

Ophthalmology (Rochester, Minn.), 2009-05, Vol.116 (5), p.823-832

2009

Volltextzugriff (PDF)

The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus

Clinical infectious diseases, 2015-07, Vol.61 (2), p.157-168

2015

Volltextzugriff (PDF)

Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis

JAMA ophthalmology, 2021-07, Vol.139 (7), p.717

2021

Volltextzugriff (PDF)

Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries

JAMA ophthalmology, 2022-04, Vol.140 (4), p.345

2022

Volltextzugriff (PDF)

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

JAMA ophthalmology, 2017-05, Vol.135 (5), p.452

2017

Volltextzugriff (PDF)

Prevalence of Glaucoma Among US Adults in 2022

JAMA ophthalmology, 2024-10

2024

Volltextzugriff (PDF)

Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys

Ophthalmology (Rochester, Minn.), 2021-01, Vol.128 (1), p.15-27

2021

Volltextzugriff (PDF)

Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years

Diabetes care, 2023-04, Vol.46 (4), p.687-696

2023

Volltextzugriff (PDF)

The potential cost-effectiveness of amblyopia screening programs

Journal of pediatric ophthalmology and strabismus, 2012-05, Vol.49 (3), p.146-155

2012

Volltextzugriff (PDF)

County-Level Variation in the Prevalence of Visual Acuity Loss or Blindness in the US

JAMA ophthalmology, 2022-08, Vol.140 (8), p.831

2022

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The global burden of hepatitis E virus genotypes 1 and 2 in 2005

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

The Economic Burden of Vision Loss and Eye Disorders among the United States Population Younger than 40 Years

Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance

The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics

A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening

Cost-Effectiveness of Screening for Microalbuminuria among African Americans

Prevalence of Age-Related Macular Degeneration in the US in 2019

Bringing Eye Care to the People

Prevalence of Diabetic Retinopathy in Health Care Settings-An Early Warning Sign?

Public Attitudes About Eye and Vision Health

A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences

Prevalence of Diabetic Retinopathy in the US in 2021

The Economic Burden of Vision Loss and Blindness in the United States

Behavioral Risk Factor Surveillance System and American Community Survey Estimates of Vision Difficulty Prevalence

The Cost-effectiveness of Routine Office-based Identification and Subsequent Medical Treatment of Primary Open-Angle Glaucoma in the United States

The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus

Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis

Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

Prevalence of Glaucoma Among US Adults in 2022

Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys

Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years

The potential cost-effectiveness of amblyopia screening programs

County-Level Variation in the Prevalence of Visual Acuity Loss or Blindness in the US

Suchergebnisse filtern